SCHEMBL7779639

SCHEMBL7779639

CS(=O)(=O)c1ccc(-c2n[nH]c(C(F)(F)F)c2-c2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.49
LRRK2 Q5S007 2/20 0.47
MAPT P10636 3/20 0.45
GPR55 Q9Y2T6 3/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
KIF11 P52732 1/20 0.41
BLM P54132 2/20 0.40
ALDH1A1 P00352 1/20 0.40
NOTUM Q6P988 1/20 0.40
GYS1 P13807 2/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779958 0.89 MAPT (0.57) PTGS2LRRK2MAPTGPR55CNR1
SCHEMBL7777625 0.88 LRRK2 (0.57) PTGS2LRRK2MAPTGPR55CNR1
SCHEMBL7779773 0.87 PTGS2 (0.51) PTGS2LRRK2MAPTGPR55CNR1
SCHEMBL7780787 0.85 PTGS2 (0.50) PTGS2LRRK2MAPTGPR55CNR1
SCHEMBL6252659 0.85 PTGS2 (0.58) PTGS2LRRK2GYS1
SCHEMBL7779772 0.85 LRRK2 (0.50) PTGS2LRRK2
SCHEMBL7779584 0.85 PTGS2 (0.58) PTGS2LRRK2MAPTGPR55CNR1
SCHEMBL7780647 0.84 LRRK2 (0.49) PTGS2LRRK2MAPTGPR55KIF11
SCHEMBL7779939 0.84 LRRK2 (0.52) PTGS2LRRK2GYS1ABCC8KCNJ11
SCHEMBL7780676 0.84 LRRK2 (0.64) PTGS2LRRK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed